Clinical Trials Logo

Clinical Trial Summary

A prospective, multi-center, double blind, 2 stage, placebo-controlled, phase II study, evaluating acute intra-coronary injected collagenase prior to routine standard-of-care percutaneous revascularization procedures in subjects with chronic total coronary artery occlusions (CTOs).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Chronic Coronary Total Occlusions

NCT number NCT01753180
Study type Interventional
Source Matrizyme Pharma Corporation
Contact
Status Completed
Phase Phase 2
Start date April 2014
Completion date July 2016